Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pruritic papular eruption in HIV.

Samantha Eisman1

  • 1Division of Dermatology, Groote Schuur Hospital, Anzio Road, Observatory 7925, South Africa. samanthak@telkomsa.net

Dermatologic Clinics
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial.

Journal of the American Academy of Dermatology·2026
Same author

Alopecia Areata Prevalence in Australia: Insights From a Nationally Representative Cross-Sectional Survey Study.

The Australasian journal of dermatology·2026
Same author

Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement.

The Australasian journal of dermatology·2025
Same author

Asymptomatic lesions on the lower limbs.

Clinical and experimental dermatology·2025
Same author

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus Exercise.

The Australasian journal of dermatology·2025
Same author

Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Pruritic papular eruption (PPE) is a chronic itchy rash common in HIV patients, particularly in developing regions. Its exact cause is unknown but may involve insect bites and HIV-related immune issues.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Immunology

Background:

  • Pruritic papular eruption (PPE) is defined by chronic itching and a papular rash on the trunk and extremities in HIV-infected individuals.
  • PPE is disproportionately prevalent in less developed global regions.
  • The underlying cause of PPE remains unclear, but potential triggers include arthropod bites and immune dysregulation associated with HIV.

Purpose of the Study:

  • To elucidate the etiology and pathogenesis of Pruritic papular eruption (PPE) in HIV-infected patients.
  • To differentiate PPE from other pruritic dermatoses in the context of HIV.
  • To highlight the importance of recognizing PPE for effective patient management.

Main Methods:

  • This study involved a comprehensive review of existing literature on Pruritic papular eruption (PPE) in HIV-infected individuals.

Related Experiment Videos

  • Diagnostic criteria for PPE were analyzed, focusing on clinical presentation and exclusion of other causes.
  • Epidemiological data regarding PPE prevalence, particularly in different geographical regions, were examined.

    • Main Results:

    • Pruritic papular eruption (PPE) is characterized by persistent itching and a symmetrical papular rash.
    • A strong association with HIV infection is noted, with higher prevalence in resource-limited settings.
    • Potential pathogenic mechanisms involve aberrant immune responses to external stimuli like insect bites.

    Conclusions:

    • Accurate identification of Pruritic papular eruption (PPE) is crucial for managing HIV-associated pruritic conditions.
    • Distinguishing PPE from other itchy disorders in HIV patients is essential for appropriate treatment.
    • Further research into the specific immune dysregulation and triggers of PPE is warranted.